A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects

Clinical trial NCT01911741 · COMPLETED

Trial details

NCT number: NCT01911741
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Castration Resistant Prostate Cancer (CRPC)Relative Bioavailability MDV3100

Start date: 2012-11-01
Primary completion: 2013-03-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.